Get short, timely messages from Sagacious Research.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @IP_Updates.

Get updates via SMS by texting follow IP_Updates to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

IP_Updates

  1. Anticipate this Patent!: Anticipate this Patent! bit.ly/LmaBLm
  2. Anticipate this Patent! p.ost.im/p/etVVbD
  3. Pharma & Biotech Global Week in Review 16 May 2012 from IP Think Tank p.ost.im/p/etXTYg
  4. Prosecution History Estoppel Flows to Progeny p.ost.im/p/etjA3Y
  5. An article describing how Authorship Claims Are Not False Designation of Origin: An article describing how Autho... bit.ly/Lggai7
  6. An article describing how Authorship Claims Are Not False Designation of Origin p.ost.im/p/etM9WP
  7. Chinese search giants Baidu Rockets Higher On New Smartphone with patent arsenal p.ost.im/p/etkkMN
  8. How Dismissal Without Prejudice Will Allow Parties to Reassert Unexhausted Claims: How Dismissal Without Prejudi... bit.ly/Klbiq8
  9. How Dismissal Without Prejudice Will Allow Parties to Reassert Unexhausted Claims p.ost.im/p/etrEP8
  10. Pro Se Defendant Granted Leeway re: Local Rule 56.1: A report & analysis: Pro Se Defendant Granted Leeway re: Lo... bit.ly/LlGnbo
  11. Pro Se Defendant Granted Leeway re: Local Rule 56.1: A report & analysis p.ost.im/p/etYpJr
  12. A case study analysis of Otsuka Pharmaceutical Co. v. Sandoz, Inc. (Fed. Cir. 2012) p.ost.im/p/etjCVR
  13. A case study analysis of re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation: A case stu... bit.ly/My5xpZ
  14. A case study analysis of re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation p.ost.im/p/et2Ehy
  15. USPTO Announces Quick Path Information Disclosure Statement Pilot Program: USPTO Announces Quick Path Informati... bit.ly/LlwGd4
  16. USPTO Announces Quick Path Information Disclosure Statement Pilot Program p.ost.im/p/etfUay
  17. Patent Success or Failure? The America Invents Act and Beyond: Patent Success or Failure? The America Invents Ac... bit.ly/LGPoBI
  18. Patent Success or Failure? The America Invents Act and Beyond p.ost.im/p/etDWpa
  19. BIO & GW GW to hold Roundtable on Patent-Eligible Subject Matter: BIO & GW GW to hold Roundtable on Patent-Eligi... bit.ly/LGEoo4
  20. BIO & GW GW to hold Roundtable on Patent-Eligible Subject Matter p.ost.im/p/et5mAR